/
PCLOF
$0.06+$0.01 (+27.77%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.12
51% from low
Exchange
OTC Link
OS
Borrow rate
0.54%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-0.71
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $786.9K | $2.7M | $1.9M | $5.3M | $1.5M | $3.5M | $2.6M |
| Cost of revenue | $653.6K | $2.4M | $9.3M | $6.3M | $4.6M | $2.9M | $2.7M | $2.0M |
| Gross profit | −$653.6K | −$1.7M | −$6.6M | −$4.3M | $681.3K | −$1.4M | $730.9K | $633.0K |
| Gross margin | — | -210.9% | -250.0% | -221.5% | 12.8% | -88.8% | 21.0% | 24.3% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$118.6K | −$34.3M | −$43.4M | −$25.2M | −$11.4M | −$9.7M | −$4.9M | −$3.8M |
| EBITDA | −$23.8M | −$33.2M | −$41.9M | −$24.8M | −$10.5M | −$12.2M | −$4.6M | −$1.3M |
| Net income | −$31.6M | −$34.7M | −$43.8M | −$26.6M | −$14.5M | −$16.3M | −$9.1M | −$4.0M |
| Net margin | — | -4405.6% | -1648.7% | -1369.1% | -273.5% | -1057.1% | -262.7% | -153.0% |
| EPS (diluted) | -1.18 | -0.36 | -0.39 | -0.18 | -0.10 | -0.10 | -0.05 | -0.01 |
Annual figures · source: Financial Modeling Prep
Peer comparison
PHARMACIELO LTD
PHARMACIELO LTD
Held by traders on TradeandTell
No one on the platform currently holds PCLOF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PCLOF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2019-01-18 | 1-for-11.94reverse |
Recent trades on TradeandTell
No one on the platform has traded PCLOF yet.